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Several intracoronary echo contrast agents that provided
satisfactory regional myocardial delineation with two-
dimensional echocardiography were compared in 15 dogs
and their effects on coronary blood f1QW were examined.
Reproducible delineation of myocardium subserved from
the intracoronary echo contrast injectiQn site was achieved
with hand-agitated agents containing ~30% Renografin,
~30% glucose, ~30% sucrose or 6% dextran. After a
2cc injectiQn of the echo contrast agent, peak hyperemic
augmentation of coronary flow was 56.7 ± 54.4% for
6% dextran, 116.0 ± 71.1 % for 30% Renografm, 119.3
± 47.8% for 30% sucrose, 173.8 ± 38.3% for 30%
glucose. AlthQugh, 6% dextran resulted in the lowest
Myocardial contrast two-dimensional echocardiography with
intracoronary agent administration is a recently reported
method (1-4) for delineating myocardial perfusion defects
or outlining myocardium subserved from an intracoronary
contrast injection site. Our initial studies described a 2:3
hand-agitated Renografin-saline mixture that provided clear
and reproducible delineation of regional canine myocar-
dium. Validations in closed chest dogs indicated that the
saline-Renografin echo contrast allowed measurement of
perfusion defects caused by a coronary occlusion (4).
Computer analysis of myocardial echo contrast appear-
ance-disappearance observed in two-dimensional echo-
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and shortest hyperemic response of the four agents, com-
puter-derived echo contrast appearance-disappearance
analysis indicated a prolonged myocardial contrast de-
cay half-life (21.0 seconds). On the other hand, 30%
Renografin had a more rapid myocardial echo contrast
washout (TVz =15.5 seconds), but a significantly greater
hyperemic f,!ffect was observed. It is concluded that de-
velopment of echo contrast agents for myocardial con-
trast two-dimensional echocardiographlc assessment of
myocardial perfusion will require consideration of al-
terations in coronary flow due to contrast-induced
hyperemia.
graphic cross sections is aimed at characterizing myocardial
perfusion and coronary blood flow. The most recent studies
employed contrast solutions containing very small gaseous
microbubbles compatible with myocardial transcapillary
passage, thus facilitating appropriate echo contrast washout
analysis. Minimal microbubble size is obviously also ex-
tremely desirable for right-sided or intravenous contrast in-
jections envisioned for future myocardial echo contrast stud-
ies. Unfortunately, the smallest and optimally persisting
microbubbles might be produced in the more viscous and
dense solutions, which, in tum, tend to cause the greatest
changes in coronary blood flow from its undisturbed state
when the echo contrast agent is injected into the coronary
artery. Thus, contrast-induced hyperemia could cause a very
substantial increase in myocardial perfusion during the con-
trast echocardiographic procedure.
The current study was designed to examine several se-
lected intracoronary myocardial echo contrast agents in terms
of their: I) reliability in delineating regional myocardium,
2) hyperemic response, and 3) observed myocardial echo
contrast washout, It is hoped to clarify differences in hy-
peremia that might significantly alter myocardial echo con-
trast appearance-disappearance and, thus, interfere with the
ability of computer analysis to characterize myocardial per-
fusion (5,6).
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Methods
Experimental preparation. Fifteen dogs (eight closed
chest and seven open chest) weighing 18 to 55 kg were used
for the experiments. Intramuscular morphine (2 mg/kg body
weight) and intravenous pentobarbital (30 mg/kg) were used
for anesthesia. A Harvard ventilator was applied for ven-
tilation through a cuffed endotracheal tube. A pigtail cath-
eter and an 8F catheter were inserted into the left ventricle
and the ascending aorta, respectively. To measure blood
pressures, P23Db pressure transducers with fluid-filled cath-
eters were used. A precordial lead electrocardiogram and
intracardiac pressures were monitored on a physiologic mul-
tichannel recorder (model 12, Honeywell) at a paper speed
of 25 or 10 mm/s. In the seven open chest dogs, an elec-
tromagnetic flow probe was placed onto the mid left cir-
cumflex coronary artery, and coronary flow was measured
using an electromagnetic flowmeter (AC 1000, Micron In-
struments). In all the dogs, a 2F catheter was inserted under
fluoroscopic control through the left carotid artery into the
left circumflex coronary artery, with the catheter tip posi-
tioned at a proximal site.
Glucose (10 to 50%) or sucrose (10 to 50%) solutions
were prepared with distilled water, and Renografin (10 to
76%) solutions with saline. Commercially available 6% dex-
tran was also used in the experiments. A 2 ml bolus of any
one of these solutions was hand-agitated by flushing through
two syringes, and was then injected through the 2F catheter
into the left circumflex coronary artery. Subsequent injec-
tion was performed only after sufficient time had passed to
allow coronary flow to fully return to control levels.
Coronary flow measurements. The coronary flow re-
sponse after contrast injections was measured by the cali-
brated electromagnetic flowmeter method. Simultaneously,
the time course of two-dimensional echographic myocardial
contrast opacification was recorded in a left ventricular short-
axis cross section.
Peak hyperemic coronary flow ratio was calculated from
coronary flow measurements as follows:
(Peak - Control)/Control x 100%.
Initial minimal coronary flow ratio was calculated as
follows:
(Control - Lowest)/Control x 100%.
The times from contrast injection to peak hyperemic flow
and from injection to minimal flow and the overall duration
of hyperemia were measured.
Two-dimensional echocardiographic examination. A
two-dimensional echocardiographic system (ATL, Mark III)
was used. The dog was placed on its right side on a table
with a special cutout and the 3 MHz transducer was directed
upward against the right side of the chest. Of multiple re-
corded short-axis cross sections of the left ventricle, one
papillary level section was selected in each dog and recorded
throughout the experiment.
Echographic equipment gain settings were adjusted at the
beginning of the study and were not changed throughout
the experiment. The two-dimensional echocardiograms were
recorded on videotape, and the images could be replayed
in real time, slow motion or as single frames. The chosen
short-axis cross section of the left ventricle was used to
draw onto transparent paper epicardial and endocardial in-
terfaces at end-diastole (peak of the electrocardiographic R
wave and largest luminal area) and end-systole (smallest
size of section). The images were digitized and analyzed
with the help of a computer (PDP 11134) that automatically
divided, in a standardized fixed referencing system, each
short-axis cross section into eight equiangular (45°) seg-
ments. On the basis of the endocardial outline areas, the
computer calculated, for each section and each of its seg-
ments, the respective systolic fractional area change (FAC)
as follows:
FAC% = 100 (End-diastolic area - End-systolic area)
lEnd-diastolic area.
For study of myocardial contrast delineation, borders of
the opacified region in the echographic cross section were
determined first and then drawn onto transparent paper. The
extent of the opacified zone was measured in circumferential
degrees. Duplicate intraobserver studies (separated by 24
hours) and contrast agent injection to injection reproduci-
bility studies (one observer for two different injections) were
performed.
Analysis of myocardial contrast washout. For each
contrast injection, 18 to 20 end-diastolic two-dimensional
echocardiographic left ventricular short-axis cross-sectional
images were digitized by an image processing computer.
The end-diastolic echographic frames were analyzed on a
beat to beat basis immediately before and during the early
contrast injection period, followed by progressively increas-
ing intervals, with the final two frames separated by 30
seconds. Epicardial and endocardial outlines were drawn
for each of the end-diastolic frames, with the papillary mus-
cle omitted. A computer program automatically divided each
of the short-axis cross sections into 12 segments, using an
indexing line connecting the center of the gravity of the
endocardium to the endocardial anterior junction of the an-
terior papillary muscle. A special computer algorithm then
determined the average echo contrast intensity within each
of the 12 segments. Myocardial echo contrast in the ven-
tricular segments was analyzed for contrast disappearance
("washout"). Subtraction of the intramyocardial echo in-
tensity just before contrast injection served to normalize the
myocardial contrast disappearance curve. Echo intensity
changes between a peak (representing full "wash in" of the
contrast agent into the myocardium) and a "baseline" at
10% of the peak intensity level were used to fit an expo-
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Figure I. Myocardial delineation with
four different contrast agents (A. 30%
Renografin; B, 6%dextran; C, 50%su-
crose and D, 50% glucose). These two-
dimensional echocardiographic images
of a short-axis cross section were ob-
tainedafter injection ofthe contrast agents
through a 2F catheter in the proximal
left circumflex coronaryartery. All four
agents allowed delineation of the region
subserved from this artery (arrows) .
Correlation Coefficients
Table I. Intraobserver and Injection to Injection
Reproducibility of Two-Dimensional Echo Delineation of
Regional Myocardium With Different Contrast Agents
(echographically derived systolic fractional area change) from
control to intracoronary contrast-induced peak hyperemia.
There was no significant change in heart rate and blood
pressure. With administration of 50% glucose (uncorrected
for pH) there were frequent premature ventricular complexes
during the injections (48% of 39 injections), and in some
dogs signifi cant ST elevation was also observed. After the
contrast agent injections, transient T wave depression was
common, but the longest duration was 48 ± 28.3 seconds
(30% Renografin). Intracoronary injection of 6% dextran
and 30% Renografin caused a very brief reduction in the
first derivative of left ventricular pressure (dP/dt) (24 ± 12
and 16.6 ± 9.5 seconds. respectively). Two-dimensional
echographic measurements of systolic fractional area change
nential curve through the end-diastolic points from which a
contrast time-activity decay half-life (tV2) was calculated.
Statistical analysis. Results were expressed as mean ±
standard deviation and statistical evaluation used the Stu-
dent' s t test for paired data. Reproducibility and the relation
of contrast solution concentration to peak hyperemic flow
ratio were analyzed with linear regression analysis.
Results
Figure 1 illustrates stop frame two-dimensional echo-
graphic delineation of regional myocardium with four dif-
ferent echo contrast agent solutions (30% Renografin, 50%
glucose. 50% sucrose and 6% dextran) injected at a rate of
2 cc over 5 seconds through a 2F catheter positioned in the
proximal circumflex coronary artery. In all these echo con-
trast studies, satisfactory delineation of the myocardial re-
gion subserved from the selective coronary injection site
was achieved. Table I summarizes results of intraobserver
and injection to injection reproducibility studies of the extent
of contrast-outlined myocardium using the four echo con-
trast agents. Correlation coefficients were I' greater than
0.933 for duplicate studies and I' greater than 0.953 for
repeat injections.
Table 2 lists alterations in hemodynamics, electrocardio-
gram and regional mid left ventricular contractile function
6% dextran
50% glucose
30% glucose
50% sucrose
30% sucrose
30% Renografin
Intraobserver
0.987
0.996
0.933
0.980
0.969
0.998
Injection to Injection
0.972
0.988
0.985
0.953
0.963
0.987
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Table 2. Peak Changes in Hemodynamics. Function and Electrocardiogram Due to Injection of Myocardia l Contrast Agents (mean
values ± standard deviation)
ECG Changes
HR (beats/min)
Maximal Duration
Systolic AoP (mm Hgl
Control Injection Type (seconds) (seconds) Control Injection
6% dextran 102.7 :!: 33.8 105.9 ± 33.2 T 6.3 ± 1.2 23.2 :!: 9 .6 145.2 ± 26.9 142.4 ± 25.4
50% glucose 120. \ ± 27.4 1\ 8,4 == 28.0 PVC;ST-T 7.7 :!: \.6 25 :!: 7.3 142.2 ± 29,4 138.5 ± 30.0
50% sucrose 130.8 ± 15.2 130.2 ± 17.2 T 5.6 ± 1,4 28 ± 8.3 1311.3 ± 33.3 136.9 :!: 32.8
30% Renografin 107.3 ± 33. \ 108.8 ± 3\.6 T 6.6 ± \.6 48 ± 28.3 137.9 ± 25.7 135. 1 ± 24.5
End-diastolic AoP (mm Hg) LV dP/dt (mm Hg/s) LVEDP (mm Hg) FAC (%)
Control Injection Control Injection Control Injection Control Injection
6% dextran ' 105.0 ± 24.6 102.1 ± 18.8 1,576 ± 561 1,367 ± 369* 3. 1 ± 1.I 3.5 ± 1.8 38. 1 ± 9.9 39,4 ± 10.8
50% glucose 105.5 ± 25.9 101.1 ± 25.2 1,581 ± 434 1,639 ± 467 3.0 ± \.6 4.0 ± 2.0 t 4\.4 ± 14.0 44.7 ± I\.6
50% sucrose 105.9 ± 27.2 103.8 ± 29.0 1,556 ± 454 1,547 ± 450 3.1 ± \.0 2.8 ± 0.7 43.3 ± 10.3 44.7 ± 12.7
30% Renografin 99 .5 ± 22.7 98.5 ± 21.7 1,572 ± 394 1,483 ± 388* 2.8 ± 1.6 3.3 ± 1.8 43.5 ± 7.2 46 .5 ± 9.5
*p < 0.05 versus control; t p < 0.005 versus control. AoP = aortic pressure; dP/dt = first derivative of left ventricular pressure; ECG =
electrocardiogram; FAC = fractional area change; HR = heart rate; LV = left ventricle; LVEDP = left ventricular end-diastolic pressure; PVC =
premature ventricular complex.
(FAC) showed no significant changes as a result of the
various intracoronary contrast injections (Table 2).
Figure 2 illustrates circumflex coronary artery flow mea-
surements in the control state and after intracoronary injec-
tion , using hand-a gitated Renografin-saline solutions of two
different concentrations (10 and 50% Renografin). As can
be seen, the more concentrated 50% Renografin echo con-
trast resulted in a much higher and more extended peak
hyperemic flow augmentation and longer overall duration
of hyperemia as compared with the more dilute 10% Ren-
ografin solution (166.8 ± 93.4%, 38 ± 7.1 seconds versus
55.7 ± 23.9%, 17.4 ± 2.4 seconds, respectively).
Table 3 provides more detailed analysis of circumflex
coronary artery flow recordin gs with intracoronary injec-
tions of six different Renografin concentrations (10. 20, 30.
40,50 and 76%). It is seen that increasing the concentration
of Renografin leads not only to success ively higher peak
hyperemic flow levels, but also to more profound transient
Figure 2. Left circumflex coronary
artery flow measurements in one dog
before and after intracoronary injec-
tion of 10 and 50% solutions of Ren-
ografin. This figure illustrates tracings
of coronary blood flow, electrocardio-
gram and aort ic and left ventricular
pressure before and after injection of
the contrast agents. Injection of 50%
Renografin caused obviously higher
hyperemic coronary flow as compared
with 10% Renografin . Ao = aortic;
ECG = electrocardiogram; LV = left
ventricular; sec = second.
LV PRESSUlE
,_ 50% RENOGRAFN
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Table 3. Effect of Renografin-Saline Concentration on Hyperemic Response (mean values ± standard deviation)
Renografin Concentration
C'oronary Flow 10% 20% 300k 40% 50% 76%
- - --
Peak hyperemic ratio (%j 55.7 ± 23.9 79 ± 46.1 116 ± 77. 1 149.5 ± 84.1* 166.8 ± 93.4* 240 ± 81.5t
Minimal postinjection ratio (%) 21.5 ± 23.0 23.8 ± 33.8 25.8 ± 30.6 33.6 ± 31.0 42.8 ± 30.5' 42.2 ± 12.7'
Time to peak (seconds) 7.3 ± 2.2 9 :!: 1.6 10.3 ± 2.9 11.5 ± 3.0 11.5 ± 3.6 17.4 :!: 3.0*
Time to minimum (seconds) 1.7 ± 0.5 1.3 ± 0.5 2.3 z; 1.2 2.8 ± 0.4' 3.3 ± 0.4' 3.4 ± 1.4*
Duration of change (seconds) 17.4 ± 2.4 26 :!: 8.8 31.2 ± 8.7* 38 ± 8.9* 38± 7.1* 55.7 ± 4.0t
*p < 0.05 versus 10% Renografin: t p < 0.005 versus 10% Renografin. Peak hyperemic ratio = peak hyperemic coronary flow ratio: (Peak -
Control j.Control x 100%. Minimal postinjection rate = minimal postinjection coronary flow ratio: (Control - Lowest/Control) x 100%.
coronary flow reductions early after bolus intracoronary in-
jection of the contrast agent. Higher contrast concentrations
also extended the time from contrast injection to peak hy-
peremic flow and increased the overall duration of the hy-
peremic changes induced by the contrast agent. The cor-
relation coefficients betweenconcentrations of the Renografin-
saline solution and measured peak hyperemic coronary flow
rates studied in the dogs ranged from 0.895 to 0.993. The
equation relating mean Renografi n concentration (C) to hy-
peremic coronary blood flow (F) was: F = 28.C + 28.5.
Figure 3 compares in one dog changes in circumflex
coronary artery flow resulting from intracoronary injections
of a 2 ml bolus of 6% dextran or 50% glucose, both of
which provided satisfactory regional myocardial echo con-
trast delineation. Injection of 50% glucose caused a much
higher nyperemic flow augmentation than did injection of
6% dextran (338 ± 83.5 versus 56.7 ± 54.4%, respec-
tively), and the hyperemia was also substantially longer in
duration (64.8 ± 21.3 versus 10.6 ± 5.1 seconds,
respectively).
Table 4 presents the results of a computer analysis of
regional myocardial contrast echo appearance-disappear-
ance, as well as detailed coronary flow measurements after
intracoronary injection of the four different contrast solu-
tionsof selected minimalconcentrationstill compatible with
reproducible echo contrast delineation of perfused regional
myocardium. Thus, peak myocardial echo intensity, time
to peak and decay (washout) half-life (t'/ 2) were derived as
potential indexes of myocardial blood circulation. Injection
of 30% glucose resulted in the highest peak hyperemic flow
ratio (173.8 ± 38.3%) and longest duration of hyperemic
response (28.3 ± 8.1 seconds), whereas 6% dextran re-
sulted in the lowest values (56.7 ± 54.4%, 10.6 ± 5.7
seconds). In contrast, washout tV2 was longest with 6%
dextran (21.0 ± 4.5 seconds); t'l2 of 50% glucose was
significantly shorter (15.9 ± 4.2 seconds, p < 0.02). Data
fO£CT 6% DEXTRAN
I ~ I I F1 I I I I I I I I I I I I I I I I I I ! I I I
ECG
50% GWCOSEFi I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
! I hi ! I I 1 1 I I I ! ! I I ! ! ! ! I ! , I I , ! , , , , I , ,
NJECT
I ~ I I
Figure 3. Circumflex coronary artery
flow measurements before and after in-
tracoronary injection of 6% dextran and
50% glucose solutions in one dog. The
tracings indicate that 50% glucose is as-
sociated with a major hyperemic re-
sponse, while 6% dextran caused only
minimal hyperemic changes in coronary
now. At) = aortic; ECG = electrocar-
diogram; LV = left ventricular; sec =
second.
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Table 4. Regional Myocardial Hyperemic Response and Myocardial Echo Contrast Dynamic s for the Four Contrasts Agent s Studied
(mean values ± standard deviation)
Coronary flow
Peak hyperemic ratio (%)
Minimal postinjection ratio (%)
Time to peak (seconds)
Time to minimum (seconds)
Duration of change (seconds)
Echo contrast intensity
Peak intensity
Time to peak (seconds)
Washout t '12 (seconds)
6% Dextran
56.7 :!: 54.4
28.8 :!: 22.9
7.8 :!: 2.9
3 :!: 0.7
10.6 ± 5.7
30 .7 :!: 5.9
4.4 :!: 1.I
21.0 :!: 4 .5
30% Renografin
116 :!: 77. 1*
25.8 ± 30.6
10.3 ± 2.9
2.3 :!: 1.2
31.2 ± 8.7*
42.6 :!: 5.8*
5.2 ± 2.2
15.5 :!: 2.2
30% Sucrose
119.3 ± 47 .8*
61.9 :!: 22.3
6.6 ± 0.8
2.5 :!: 0.9
22.8 ± 5.0*
43.5 :!: 5.8t
5.8 :!: 1.0
18.1 :!: 1.3
30% Glucose
173.8 :!: 38.5*
76.0 :!: 21.0 *
9 :!: 3.6
3 ± 0 .6
28.3 ± 8.l t
37.1:!: 11.7
6.5 :!: 4 .1
18.3 :!: 5.5
*p < 0.05 versus 6% dextran; tp < 0.01 versus 6% dextran. Minimal postinjection ratio = minimal postinjection coronary flow ratio (Control -
Lowest/Control) x 100%. Peak hyperemic ratio = peak hyperemic coronary flow ratio (Peak ~ Controlj/Control x 100%.
for the other agents were intermediate between these two
extremes.
Discussion
Prior closed chest dog studies in our laboratory (4) proved
that myocardial contrast two-dimensional echocardiography
with intracoronary injection of a 3:2 saline-Renografin echo
contrast medium ( = 30% Renografin solution) provided re-
liable delineation of severely underperfused myocardium
distal to an acute coronary artery occlusion . As attested by
intraobserver and injection to injection reproducibility stud-
ies in the current investigation , several other selected con-
trast agents (6% dextran , 30 and 50% glucose, 30 and 50%
sucrose and 30% Renografin) also provided satisfactory de-
lineation of the regional myocardium subserved from the
site of an intracoronary contrast injection. Injection to in-
jection measurement error for these agents ranged from 2.9
± 2.6 to 10.0 ± 4.9% (maximal % error 18.6%). We
examined heart rate, aortic and left ventricular pressures,
echographically derived regional contractile function and
electrocardiographic patterns during intracoronary injection
and , in general , found very few and only very brief changes
(Table 2) .
Detailed investigation provided data on initial depre ssion
of and subsequent peak hyperemic coronary flow, as well
as on durations from injection to minimal or peak flows and
overall duration of hyperemic changes. As anticipated, a
good correlation could be demon strated between concen-
tration of the contrast agent and peak hyperemic response .
Examination of echo contrast agent s of minimal concentra-
tion compatible with reliable myocardial delineation (that
is, 6% dextran, 30% Renografin , 30% sucrose and 30%
glucose) permitted a comparison to be made between the
contrast-coronary flow hyperemia and regional myocardial
echo contrast appearance-disappearance indexes extracted
by computer from two-dimensional echographic short-axis
cross sections. Injection of 6% dextran was found to result
in the smallest and shortest hyperemic response of all the
agents studied, but its echo contrast washout tY2was longer,
whereas 30% glucose resulted in the greatest and longest
hyperemic response with a shorter washout t l/ 2 .
Limitation of the method. Becau se myocardial echo
contrast procedures have not as yet been sufficiently studied
or standardized, effects of intracoronary contrast injections
on coronary flows and the computer analysis of regional
myocardial echo contrast appearance-disappearance still ex-
hibit substantial variability. Improved reproducibility of the
contrast injection method requires the same amounts and
concentration of injectate solution , with equi valent size and
distribution of gaseous microbubbles, administered at a given
coronary site with controlled force and speed. While primary
emphasis is now being placed on developing agents with
minimal size microbubbles facilitating physiologic micro-
circulatory transit, the current study employed hand-agitated
solutions with small size gaseous bubbles that were produced
by multiple reverse flushing (> 15 times with two syringes
through a three way stopcock) . Intracoronary bolus injection
of a high viscosity contrast agent may approach a brief
coronary artery obstruction followed by hyperemic response
on release , making interpretation of measurements difficult
(7) .
The study of myocardial echo contrast images requires
a stable two-dimensional echographic transducer position .
Contrast oversaturation , insufficient contrast intensity, echo
dropouts and subjectivity of endocardial and epicardial de-
lineation are some of the factor s that may produce highly
variable results.
Effects of intracoronary contrast agents. Prior studies
(8 ,9) of I to 2 cc contrast agent injection into a coronary
artery reported minor chan ges in hemodynamics or con-
tractile function, along with brief electrocardiographic T
wave depression. However, coronary artery injection of
contrast medium generally cause s a substantial perturbation
in the coronary flow. This includes an initial reduction in
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coronary flow presumably because of the viscosity of the
injected bolus (9), followed by a major and longer period
of hyperemia attributed to several factors, such as high
osmolarity (7,10,11). Injections of 20% saline and 50%
dextrose solutions were reported (12) to cause a hyperemic
flow response in the femoral artery. Significant hemody-
namic and coronary effects have been reported with 50%
glucose (13).
We observed that 6% dextran resulted in the lowest hy-
peremic response, perhaps because this polysaccharide with
a high molecular weight (average 70,000) exhibits a lower
osmolarity (310 mOsmlliter) as compared with sucrose and
Renografin (1648 mOsmlliter) (14). Injection of radiopaque
solutions was shown to cause a sudden increase in plasma
volume and plasma osmolarity and decrease in blood he-
matocrit (15). In another study (16), coronary injection of
diatrizoate caused a marked decrease in coronary sinus blood
hematocrit, hemoglobin and protein, indicating a large shift
of tissue fluid into vessels. Yet other probable mechanisms
are a decrease in vascular tone mediated, in part, neuro-
logically and a decrease in vascular resistance due to a direct
effect of the hyperemic material on arterioles. A reflex de-
crease in vascular resistance which can be prevented by
ganglionic blockade has been demonstrated after systemic
angiography (17). Conversely, it was observed that in-
creases in femoral artery flow after hypertonic injections in
451seel
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Figure 4. Simultaneous registration of myo-
cardial contrast echo appearance-disappear-
ance curve derived from two-dimensional
echocardiographic computer analysis, and
changes in left circumflex coronary blood flow
after intracoronary injection of 6% dextran
and 50% glucose solutions in the same dog.
Injection of 50% glucose caused a major hy-
peremic increase in coronary flow, while the
corresponding contrast echo "washout" half-
life (t 1/2) was 14.7 seconds. Such hyperemia
would lead to myocardial contrast echo data
representing the steep change in coronary flow
from its resting state. Injection of 6% dextran
caused a minimal and brief hyperemic re-
sponse, while the echo contrast "washout"
time was longer (t 1/2 = 22.3 seconds). In
the case of 6% dextran, the washout phase
of the echo contrast appearance-disappear-
ance curve occurred largely after completion
of the minor hyperemic deviation from con-
trol flow. Ao = aortic; ECG = electrocar-
diogram; LV = left ventricular; sec = second.
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dogs were unchanged after denervation of the leg (12).
Whether this is due to a reduction in vascular smooth muscle
tone or to loss of fluid in the vessel wall with increased
luminal size has not been determined.
Intracoronary echo contrast criteria. For most of the
hand-agitated contrast agents examined, the time from con-
trast injection to the hyperemic peak overlapped the echo
contrast washout period, potentially precluding accurate
myocardial contrast echographic assessment of coronary flow
at rest. The shorter computer-derived tV2 values of some
agents (as compared with 6% dextran) could be associated
with smaller microbubbles, but may also be due to a more
substantial hyperemic response which could be expected to
shorten echo contrast washout. For intracoronary 6% dex-
tran, time from injection to contrast disappearance t'/2 (25.4
seconds) was much longer than the duration of its hyperemic
coronary response flow (10.6 ± 5.7 seconds). Thus, such
rapid hyperemia may not significantly affect the echo con-
trast washout, and could theoretically characterize coronary
flow at rest. Figure 4 illustrates the relation of echo contrast
washout to the time course of coronary flow in one of the
dogs studied. The hand-agitated 6% dextran t1/2 (21.8 sec-
onds) was excessive compared with physiologic transit times;
however, it featured minimal hyperemia lasting only 12
seconds. This compared with a pronounced hyperemic re-
sponse (285%) for 50% glucose lasting 53 seconds (tV2 =
14.7 seconds). We found that a hand-agitated 30% Reno-
grafin-saline mixture had a wide range of gaseous micro-
bubbles with a mean diameter of 16 /1-, which is too large
for unimpeded transcapillary flow. Similarly, hand-agitated
6% dextran also contained microbubbles of excessive size.
An ideal contrast agent would be one that could provide
very small microbubb1es permitting unhindered microcir-
culatory transit, while also causing minimal hyperemic
changes in coronary and myocardial blood flow.
Potentials and future research. In human beings, it is
clearly desirable to use the smallest size of gaseous micro-
bubbles in the echo contrast agents. Smaller and more stable
bubbles might be achieved with the more viscous and con-
centrated solutions (18), but hyperemic effects need to be
considered. Published data (19) indicate that both agent-
induced coronary vasodilation and viscosity effects can in-
fluence the coronary flow, sometimes in opposite directions.
It appears possible that an intermediate dextran concentra-
tion with an improved means of controlled agitation such
as sonication (18), might provide a satisfactory balance be-
tween a low degree of echo contrast-induced hyperemia and
a minimal bubble size, both of which are needed for as-
sessment of physiologic perfusion with myocardial contrast
echocardiography. Further investigations are required in this
promising but complex area; however, any of the eventually
selected echo contrast agents will have to be examined in
terms of hyperemia, particularly when the new myocardial
contrast method is to be used for evaluation of the coronary
and myocardial blood flow.
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